Company Filing History:
Years Active: 2015
Title: Ádám Demeter: Innovator in Pharmaceutical Crystallization
Introduction
Ádám Demeter is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on organic compounds. With a focus on creating novel crystalline forms, Demeter has succeeded in obtaining a patent for his groundbreaking invention.
Latest Patents
Ádám Demeter holds a patent for the "Crystal form of an organic compound and process for the preparation thereof." This patent relates to the novel crystalline Form II of 17α-acetoxy-21-methoxy-11β-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione, also known as CDB-4124. His invention outlines processes for the preparation of this organic compound and includes pharmaceutical compositions that encompass it. Notably, Form II can be crystallized from various media, including esters of C1-C4 alcohols, carboxylic acids, ketones, cyclohexane, acetonitrile, dimethylformamide, dimethyl sulfoxide, water, and their mixtures.
Career Highlights
Demeter is currently employed at Richter Gedeon Nyrt., a prominent pharmaceutical company known for its innovative contributions to the industry. His role as an inventor at the company has allowed him to work on cutting-edge projects that impact healthcare and medicine. His expertise in organic compounds and crystallization processes demonstrates his impressive skill set and commitment to advancing pharmaceutical science.
Collaborations
Throughout his career, Ádám Demeter has collaborated with talented professionals such as Attila Balázs and János Csörgei. These collaborations have fostered a creative environment that encourages innovation and the pursuit of excellence in pharmaceutical development. Together, they contribute to the research and advancement of new treatments and drug formulations.
Conclusion
Ádám Demeter stands out as an accomplished inventor whose work has the potential to significantly influence the pharmaceutical industry. With his patented crystalline organic compound and processes for its preparation, Demeter exemplifies the spirit of innovation that drives progress in medicine and healthcare. His ongoing contributions at Richter Gedeon Nyrt. and collaborations with fellow researchers pave the way for future advancements in the field.